Monitoring adverse events of new drugs: a programmatic need stimulating operational research

Int J Tuberc Lung Dis. 2020 Apr 1;24(4):360-361. doi: 10.5588/ijtld.19.0667.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Operations Research*
  • Pharmaceutical Preparations*

Substances

  • Pharmaceutical Preparations